COST-EFFECTIVENESS OF SABR IN OLIGOMETASTATIC CANCER: AN ECONOMIC ANALYSIS BASED ON LONG-TERM RESULTS OF THE SABR-COMET RANDOMIZED TRIAL Conferences uri icon

  •  
  • Overview
  •  
  • Research
  •  
  • Additional Document Info
  •  
  • View All
  •  

authors

  • Qu, Melody
  • Chen, Yujie
  • Zaric, Gregory
  • Senan, Suresh
  • Olson, Robert
  • Harrow, Stephen
  • John-Baptiste, Ava
  • Gaede, Stewart
  • Mulroy, Liam
  • Schellenberg, Devin
  • Senthi, Sashendra
  • Swaminath, Anand
  • Kopek, Neil
  • Liu, Mitchell
  • Warner, Andrew
  • Rodrigues, George
  • Palma, David
  • Louie, Alexander

publication date

  • October 2021